Gainers
Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) surged 76.3% to $3.2450 after the company announced initial dose escalation data demonstrated anti-tumor activity of BDTX-1535 in non-small cell lung cancer patients across multiple EGFR mutation families.
Centogene N.V. (NASDAQ: CNTG) rose 49% to $1.1675 after the company and Lifera formed a Saudi Arabian joint venture. Under the terms of the collaboration, the company will receive a $30 million mandatory convertible loan from Lifera.
CalciMedica, Inc. (NASDAQ: CALC) climbed 37% to $4.43.
Cara Therapeutics, Inc. (NASDAQ: CARA) gained 22.1% to $3.9547. Cara Therapeutics was granted U.S. Patent #11684674: Oral formulations of kappa opioid receptor agonists.
AC Immune SA (NASDAQ: ACIU) rose 19.2% to $2.36 after the company received FDA fast track designation for anti-amyloid-beta active immunotherapy, ACI-24.060 for Alzheimer's disease.
American Equity Investment Life Holding Company (NYSE: AEL) shares gained 17.6% to $53.02 after the company announced it has received a $55 per share acquisition proposal from Brookfield Reinsurance.
American Rebel Holdings, Inc. (NASDAQ: AREB) jumped 16.6% to $5.47.
Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 16.6% to $0.0729.
IronNet, Inc. (NYSE: IRNT) gained 14.8% to $0.2067 after dropping 13% on Monday.
Astrotech Corporation (NASDAQ: ASTC) gained 13.5% to $12.95. Astrotech 13D filing showed BML Investment Partners, L.P. increased stake in the company to 13%.
Aterian, Inc. (NASDAQ: ATER) rose 13% to $0.4099.
Enovix Corporation (NASDAQ: ENVX) gained 12.1% to $14.71 after the company announced it received a purchase order to produce battery cells for the U.S. Army.
WeWork Inc. (NYSE: WE) rose 11.1% to $0.2601.
Moolec Science SA (NASDAQ: MLEC) gained 10.7% to $4.1817.
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) rose 9.9% to $7.54 as the company released 12-month topline results from the ARCH study, an open-label, single-center study assessing EDG-5506 in adults with Becker Muscular Dystrophy (BMD).
NextPlay Technologies, Inc. (NASDAQ: NXTP) surged ...
Related tickers: DMS, BDRX, TMC, CVAC, MLEC, CARA, VKTX, AKU, IHT, ISPR, WBA, SYTA, LOV, BNTC, RIDE, NBY, EVLO, TERN, ACET, ATER, YELL, ASTC, MDGL, EWTX, CALC, ACIU, SGHC, AEL, RSLS, NXTP, SNX, AREB, ENVX, U, WE, XPOF, VIEW, CNTG, IRNT, BIOL, OCFT, TIVC, SLRN, BDTX, GSRM, APLD, NKTX, BRSH, IMBI.
Read Full Article